Research graph
References from Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
